Augmentin is a long-acting dipeptidyl peptidase-4 inhibitor with the effect of inhibiting the activity of DPP-4, which is mainly suitable for patients with type 2 diabetes mellitus. Ologliptin is an oral hypoglycemic drug, the mechanism of hypoglycemia is mainly through the inhibition of DPP-4 activity and reduce the inactivation of GLP-1, increase the endogenous GLP-1 level, so as to reduce the blood glucose of patients with diabetes mellitus. However, it should be noted that some adverse reactions, such as rash, itching and other symptoms, may occur when taking Augmentin. It is contraindicated in people who are allergic to any of the ingredients of this product. Augmentin is a prescription drug and needs to be used under the guidance of a doctor, consult a specialist before use and take medication as prescribed by a doctor.